Cabot (FRA:CBT) Total Equity: €1,459 Mil (As of Mar. 2026)


FRA:CBT Cabot Corp FRA:CBT
74 GF Score
Price €75.40
GF Value €65.76
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cabot Total Equity?

Cabot FRA:CBT -4.07% 74 Total Equity is €1,459 Mil as of Mar. 2026. GuruFocus rates FRA:CBT with a GF Score™ of 74/100 and a GF Value™ of €65.76 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Cabot's total equity for the quarter that ended in Mar. 2026 was €1,459 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cabot Total Equity Historical Data

* Premium members only.

The historical data trend for Cabot's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabot Total Equity Chart

Cabot Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 926.50 1,042.32 1,318.36 1,432.59 1,452.66

Cabot Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,470.75 1,459.16 1,452.66 1,476.57 1,459.26
FRA:CBT
74GF Score
Cabot Corp FRA:CBT
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabot Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cabot's Total Equity for the fiscal year that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=3250.38-1797.72
=1,453

Cabot's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3370.905-1911.65
=1,459

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €1,459 Mil mean?
Cabot (FRA:CBT) has a Total Equity of €1,459 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Cabot and its competitors.
Is Cabot's Total Equity too high?
Cabot's current Total Equity is €1,459 Mil. Overall, Cabot has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cabot's Total Equity compare to SXT and BCPC?
Cabot's Total Equity of €1,459 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cabot and its competitors. Cabot's current Total Equity is €1,459 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (FRA:CBT) is currently considered Modestly Overvalued. The stock's GF Value™ is €65.76, compared to a current price of €75.40 — trading 14.7% above its estimated fair value. The current Total Equity is €1,459 Mil. Cabot's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cabot (FRA:CBT), the current Total Equity is €1,459 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabot (FRA:CBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cabot stock appears to be overvalued. The current stock price of €75.40 is trading 14.7% above its estimated GF Value™ of €65.76. GuruFocus considers Cabot to be Modestly Overvalued.

Key valuation signals for FRA:CBT:

  • Total Equity: €1,459 Mil
  • GF Value™: €65.76 vs. price of €75.40 (14.7% above fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the FRA:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabot Business Description

Other Exchanges CBT:USACBT:Germany
Address Two Seaport Lane, Suite 1400, Boston, MA, USA, 02210
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
74GF Score

Get the complete analysis for FRA:CBT

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€75.40
Price
€65.76
GF Value